Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Thomas P. Beresford

TitleAffiliate - VA
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PSYCH
Phone3033998020

    Collapse Research 
    Collapse research activities and funding
    R01AA007236     (BERESFORD, THOMAS P)Aug 1, 1986 - Jul 31, 1989
    NIH/NIAAA
    SCREENING EXAMINATIONS FOR COVERT ALCOHOLISM
    Role: Principal Investigator

    T32AA007477     (BLOW, FREDERIC C)Jul 1, 1990 - Jun 30, 2020
    NIH/NIAAA
    Multidisciplinary Alcoholism Research Training Program
    Role: Co-Principal Investigator

    R03AA012095     (BERESFORD, THOMAS P)Sep 30, 1998 - Nov 30, 2002
    NIH/NIAAA
    PLANNING A CLINICAL TRIAL TO PREVENT POSTTRANSPLANT ALD
    Role: Principal Investigator

    R21AA014010     (BERESFORD, THOMAS P)Apr 5, 2003 - Mar 31, 2007
    NIH/NIAAA
    Hippocampus/Pituitary Ratio: an AD Brain Injury Marker?
    Role: Principal Investigator

    R21AA016294     (BERESFORD, THOMAS P)Sep 30, 2008 - Feb 29, 2012
    NIH/NIAAA
    Neuro-immunophyllin Ligand Mechanism of Action in Reducing Alcohol Preference
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Mohamed S, Johnson GR, Chen P, Hicks PB, Davis LL, Yoon J, Gleason TC, Vertrees JE, Weingart K, Tal I, Scrymgeour A, Lawrence DD, Planeta B, Thase ME, Huang GD, Zisook S, Rao SD, Pilkinton PD, Wilcox JA, Iranmanesh A, Sapra M, Jurjus G, Michalets JP, Aslam M, Beresford T, Anderson KD, Fernando R, Ramaswamy S, Kasckow J, Westermeyer J, Yoon G, D'Souza DC, Larson G, Anderson WG, Klatt M, Fareed A, Thompson SI, Carrera CJ, Williams SS, Juergens TM, Albers LJ, Nasdahl CS, Villarreal G, Winston JL, Nogues CA, Connolly KR, Tapp A, Jones KA, Khatkhate G, Marri S, Suppes T, LaMotte J, Hurley R, Mayeda AR, Niculescu AB, Fischer BA, Loreck DJ, Rosenlicht N, Lieske S, Finkel MS, Little JT. Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial. JAMA. 2017 Jul 11; 318(2):132-145. PMID: 28697253.
      View in: PubMed
    2. Caldeo V, Hannon JA, Hickey DK, Waldron D, Wilkinson MG, Beresford TP, McSweeney PL. Control of oxidation-reduction potential during Cheddar cheese ripening and its effect on the production of volatile flavour compounds. J Dairy Res. 2016 Nov; 83(4):479-486. PMID: 27691999.
      View in: PubMed
    3. Ronan PJ, Wongngamnit N, Beresford TP. Molecular Mechanisms of Cannabis Signaling in the Brain. Prog Mol Biol Transl Sci. 2016; 137:123-47. PMID: 26810000.
      View in: PubMed
    4. Beresford TP. Medications for alcohol use disorders. JAMA. 2014 Oct 01; 312(13):1350. PMID: 25268446.
      View in: PubMed
    5. Hou J, McSweeney PL, Beresford TP, Guinee TP. Effect of curd washing on the properties of reduced-calcium and standard-calcium Cheddar cheese. J Dairy Sci. 2014 Oct; 97(10):5983-99. PMID: 25129501.
      View in: PubMed
    6. Beresford TP. Clinical assessment of psychological adaptive mechanisms in medical settings. J Clin Psychol. 2014 May; 70(5):466-77. PMID: 24691747.
      View in: PubMed
    7. Beresford TP, Wongngamnit N, Temple BA. Alcoholism: diagnosis, prognosis, epidemiology, and burden of the disease. Handb Clin Neurol. 2014; 125:3-13. PMID: 25307565.
      View in: PubMed
    8. Clark BJ, Keniston A, Douglas IS, Beresford T, Macht M, Williams A, Jones J, Burnham EL, Moss M. Healthcare utilization in medical intensive care unit survivors with alcohol withdrawal. Alcohol Clin Exp Res. 2013 Sep; 37(9):1536-43. PMID: 23647435; PMCID: PMC4045620.
    9. Beresford T, Fay T, Serkova NJ, Wu PH. Immunophyllin ligands show differential effects on alcohol self-administration in C57BL mice. J Pharmacol Exp Ther. 2012 Jun; 341(3):611-6. PMID: 22375069; PMCID: PMC3362882.
    10. Arciniegas DB, Beresford TP. Managing difficult interactions with patients in neurology practices: a practical approach. Neurology. 2010 Nov 02; 75(18 Suppl 1):S39-44. PMID: 21041770.
      View in: PubMed
    11. Kaleta P, O'Callaghan J, Fitzgerald GF, Beresford TP, Ross RP. Crucial role for insertion sequence elements in Lactobacillus helveticus evolution as revealed by interstrain genomic comparison. Appl Environ Microbiol. 2010 Jan; 76(1):212-20. PMID: 19880644; PMCID: PMC2798629.
    12. Kaleta P, Callanan MJ, O'Callaghan J, Fitzgerald GF, Beresford TP, Ross RP. Exploitation of the diverse insertion sequence element content of dairy Lactobacillus helveticus starters as a rapid method to identify different strains. J Microbiol Methods. 2009 Oct; 79(1):32-6. PMID: 19646489.
      View in: PubMed
    13. Beresford TP. What is addiction, what is alcoholism? Liver Transpl. 2007 Nov; 13(11 Suppl 2):S55-8. PMID: 17969088.
      View in: PubMed
    14. Martin B, Beresford TP. Disulfiram in context: structure and safety. J Clin Psychopharmacol. 2007 Aug; 27(4):415-7; author reply 417-8. PMID: 17632238.
      View in: PubMed
    15. Morfin JP, Kulig C, Everson G, Beresford T. Controlling for serum albumin level improves the correlation between serum fatty acid ethyl esters and blood ethanol level. Alcohol Clin Exp Res. 2007 Feb; 31(2):265-8. PMID: 17250618.
      View in: PubMed
    16. Beresford TP, Arciniegas DB, Alfers J, Clapp L, Martin B, Du Y, Liu D, Shen D, Davatzikos C. Hippocampus volume loss due to chronic heavy drinking. Alcohol Clin Exp Res. 2006 Nov; 30(11):1866-70. PMID: 17067350.
      View in: PubMed
    17. Beresford TP, Arciniegas DB, Alfers J, Clapp L, Martin B, Beresford HF, Du Y, Liu D, Shen D, Davatzikos C, Laudenslager ML. Hypercortisolism in alcohol dependence and its relation to hippocampal volume loss. J Stud Alcohol. 2006 Nov; 67(6):861-7. PMID: 17061003.
      View in: PubMed
    18. Bauer MS, McBride L, Williford WO, Glick H, Kinosian B, Altshuler L, Beresford T, Kilbourne AM, Sajatovic M. Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs. Psychiatr Serv. 2006 Jul; 57(7):937-45. PMID: 16816277.
      View in: PubMed
    19. Bauer MS, McBride L, Williford WO, Glick H, Kinosian B, Altshuler L, Beresford T, Kilbourne AM, Sajatovic M. Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial. Psychiatr Serv. 2006 Jul; 57(7):927-36. PMID: 16816276.
      View in: PubMed
    20. Beresford TP, Alfers J, Mangum L, Clapp L, Martin B. Cancer survival probability as a function of ego defense (adaptive) mechanisms versus depressive symptoms. Psychosomatics. 2006 May-Jun; 47(3):247-53. PMID: 16684942.
      View in: PubMed
    21. Beresford TP. Probabilities of relapse and abstinence among liver transplant recipients. Liver Transpl. 2006 May; 12(5):705-6. PMID: 16628700.
      View in: PubMed
    22. Kulig CC, Beresford TP, Everson GT. Rapid, accurate, and sensitive fatty acid ethyl ester determination by gas chromatography-mass spectrometry. J Lab Clin Med. 2006 Mar; 147(3):133-8. PMID: 16503243.
      View in: PubMed
    23. Beresford TP. Dear Edith Edith S. L. Gomberg, PhD January 14, 1920-January 9, 2005. Alcohol Clin Exp Res. 2006 Feb; 30(2):177. PMID: 16441264.
      View in: PubMed
    24. Beresford TP. Learning to recognize ego defense mechanisms: results of a structured teaching experience for psychiatric residents. Acad Psychiatry. 2005 Nov-Dec; 29(5):474-8. PMID: 16387973.
      View in: PubMed
    25. Weiss DB, Beresford TP, House RM. Noncompliance in neurologic patients. Curr Treat Options Neurol. 2005 Sep; 7(5):419-23. PMID: 16079046.
      View in: PubMed
    26. Beresford HF, Deitrich R, Beresford TP. Cyclosporine-A discourages ethanol intake in C57bl/6j mice: a preliminary study. J Stud Alcohol. 2005 Sep; 66(5):658-62. PMID: 16331851.
      View in: PubMed
    27. Weiss DB, Dyrud J, House RM, Beresford TP. Psychiatric manifestations of autoimmune disorders. Curr Treat Options Neurol. 2005 Sep; 7(5):413-7. PMID: 16079045.
      View in: PubMed
    28. Beresford TP, Clapp L, Martin B, Wiberg JL, Alfers J, Beresford HF. Aripiprazole in schizophrenia with cocaine dependence: a pilot study. J Clin Psychopharmacol. 2005 Aug; 25(4):363-6. PMID: 16012280.
      View in: PubMed
    29. Fenn HH, Bauer MS, Altshuler L, Alshuler L, Evans DR, Williford WO, Kilbourne AM, Beresford TP, Kirk G, Stedman M, Fiore L. Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span. J Affect Disord. 2005 May; 86(1):47-60. PMID: 15820270.
      View in: PubMed
    30. Martin B, Mangum L, Beresford TP. Use of court-ordered supervised disulfiram therapy at DVA medical centers in the United States. Am J Addict. 2005 May-Jun; 14(3):208-12. PMID: 16019971.
      View in: PubMed
    31. Beresford TP, Arciniegas D, Clapp L, Martin B, Alfers J. Reduction of affective lability and alcohol use following traumatic brain injury: a clinical pilot study of anti-convulsant medications. Brain Inj. 2005 Apr; 19(4):309-13. PMID: 15832875.
      View in: PubMed
    32. Bauer MS, Altshuler L, Evans DR, Beresford T, Williford WO, Hauger R. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. J Affect Disord. 2005 Apr; 85(3):301-15. PMID: 15780700.
      View in: PubMed
    33. Kilbourne AM, Bauer MS, Pincus H, Williford WO, Kirk GF, Beresford T. Clinical, psychosocial, and treatment differences in minority patients with bipolar disorder. Bipolar Disord. 2005 Feb; 7(1):89-97. PMID: 15654937.
      View in: PubMed
    34. Kulig CC, Beresford TP. Hepatitis C in alcohol dependence:drinking versus disulfiram. J Addict Dis. 2005; 24(2):77-89. PMID: 15784525.
      View in: PubMed
    35. Martin B, Alfers J, Kulig C, Clapp L, Bialkowski D, Bridgeford D, Beresford TP. Disulfiram therapy in patients with hepatitis C: a 12-month, controlled, follow-up study. J Stud Alcohol. 2004 Sep; 65(5):651-7. PMID: 15536776.
      View in: PubMed
    36. Beresford TP, Martin B, Alfers J. Developing a brief monitoring procedure for alcohol-dependent liver graft recipients. Psychosomatics. 2004 May-Jun; 45(3):220-3. PMID: 15123847.
      View in: PubMed
    37. Martin BK, Clapp L, Alfers J, Beresford TP. Adherence to court-ordered disulfiram at fifteen months: a naturalistic study. J Subst Abuse Treat. 2004 Apr; 26(3):233-6. PMID: 15063918.
      View in: PubMed
    38. Clapp L, Martin B, Beresford TP. Sublingual cocaine: novel recurrence of an ancient practice. Clin Neuropharmacol. 2004 Mar-Apr; 27(2):93-4. PMID: 15252272.
      View in: PubMed
    39. Martin B, Clapp L, Bialkowski D, Bridgeford D, Amponsah A, Lyons L, Beresford TP. Compliance to supervised disulfiram therapy: a comparison of voluntary and court-ordered patients. Am J Addict. 2003 Mar-Apr; 12(2):137-43. PMID: 12746088.
      View in: PubMed
    40. Brennan NM, Ward AC, Beresford TP, Fox PF, Goodfellow M, Cogan TM. Biodiversity of the bacterial flora on the surface of a smear cheese. Appl Environ Microbiol. 2002 Feb; 68(2):820-30. PMID: 11823224; PMCID: PMC126715.
    Beresford's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)